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Abstract 
Background: Psychological flexibility theory (PFT) suggests three key processes of change: 
increases in value-directed behaviors, reduction in struggle with symptoms, and reduction in 
suffering. We hypothesized that Acceptance and Commitment Therapy (ACT) would change 
these processes and that increases in valued action and decreases in struggle would precede 
change in suffering. 
Method: Data were derived from a randomized clinical trial testing ACT (vs. waitlist) for 
treatment-resistant patients with primary panic disorder with/without agoraphobia (n= 41). 
Valued behavior, struggle, and suffering were assessed at each of eight sessions.  
Results: Valued actions, struggle, and suffering all changed over the course of therapy. 
Overall changes in struggle and suffering were interdependent whereas changes in valued 
behavior were largely independent. Levels of valued behaviors influenced subsequent 
suffering, but the other two variables did not influence subsequent levels of valued action.  
Discussion: This finding supports a central tenet of PFT that increased (re-)engagement in 
valued behaviors precedes reductions in suffering. Possible implications for a better 
understanding of response and non-response to psychotherapy are discussed.  
Keywords: psychological Flexibility; ACT; valued behavior; suffering; process; 
treatment resistance  
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Changes in Valued Behaviors Precede Reduction in Suffering: Findings from a Randomized 
Controlled ACT Trial 
Implicitly or explicitly, all forms of psychotherapy aim to reduce suffering. The 
methods used to achieve this differ, however, as a function of the processes hypothesized to 
maintain patients’ suffering. Example processes that have been targeted include deficits in 
inhibitory learning (Craske et al., 2008; Craske, Treanor, Conway, Zbozinek, & Vervliet, 
2014), maladaptive schemata (Hoffart et al., 2005), personality structure (Wallerstein, 2002), 
or psychological inflexibility (Hayes, Luoma, Bond, Masuda, & Lillis, 2006). Inherent in 
these theories are assumptions about the temporal sequence of therapeutic procedures 
necessary for change. Empirical testing of these temporal sequences within a therapy is 
relatively rare, yet the identification of such patterns can immediately inform clinical 
procedures and advance clinical theory. 
Antecedent Models for the Reduction of Suffering 
Psychological flexibility theory (PFT), a comparatively recent development within the 
literature on human change processes, is a transdiagnostic approach to therapy that focuses on 
valued-action and acceptance in order to reduce suffering. Within PFT, suffering is defined as 
a negative reaction to symptoms, but not the diagnostic symptoms themselves. This may 
include such things as being upset, distraught, worried, or concerned about the occurrence, 
implication, or justice of one’s presenting symptoms. According to PFT, avoidance of internal 
states such as anxiety and fear maintains suffering; conversely increasing psychological 
flexibility decreases suffering (Gloster, Klotsche, Chaker, Hummel, & Hoyer, 2011; Hayes et 
al., 2006; Hayes, Strosahl, & Wilson, 2012; Kashdan & Rottenberg, 2010). 
Specific temporal predications about the mechanisms of change can be derived from 
PFT. First, it is believed that increased valued activity is antecedent to reductions in suffering 
(Antecedent Model 1). Values are personally and freely chosen areas of importance in one’s 
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life. Engaging with the things that one holds important is seen as the ultimate treatment goal 
and frustration of such engagement is a frequent preceptor of treatment seeking. For example, 
it has been found that patients presenting for treatment engage in less valued actions than 
controls (Michelson, Lee, Orsillo, & Roemer, 2011). Further, 75% of patients indicated their 
central treatment goal was about interpersonal issues and nearly half (46%) indicated personal 
growth as one of the most important treatment goals (Grosse & Grawe, 2002). Approximately 
60% of these patients also indicated working on specific symptoms as one of their primary 
treatment goals. Thus, values frustration, in combination with distressing symptoms, appears 
to be a salient theme for a large majority of patients.  
PFT suggests that by (re)-engaging in valued actions, the subjective meaning of 
symptoms will change and suffering will decrease. In other words, by engaging in valued 
behaviors despite the presence of symptoms, the symptoms no longer need to be viewed as 
necessary barriers and suffering begins to recede. This suggests it is possible to act in ways 
consistent with one’s values even when symptoms remain and doing so becomes an integral 
step to reducing suffering. Research is lacking, however, that directly tests whether changes in 
valued behaviors temporally precede changes in suffering, as suggested by PFT.  
A second prediction derived from PFT is that struggling with unwanted internal states 
such as thoughts, emotions, or memories by attempting to suppress, diminish, or remove them 
is believed to in fact maintain or even amplify the unwanted internal states. Technically 
speaking, the avoidance of aversive stimuli is negatively reinforced, as indicated by numerous 
laboratory studies (e.g., Levin & Hildebrandt, 2012; Levitt, Brown, Orsillo, & Barlow, 2004; 
Wenzlaff & Wegner, 2000). Clinically speaking, struggling with symptoms contributes to the 
maintenance of the patients’ presenting problem and acceptance (e.g., developing the 
willingness to experience these things) can be part of an answer to break the avoidance-
negative reinforcement-increased distress cycle. Thus, the degree to which struggle is reduced 
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is hypothesized to lead to reductions in suffering (Antecedent Model 2). Whereas numerous 
laboratory studies have documented positive effects of promoting acceptance on varied 
outcomes such as task perseverance, willingness to reengage in difficult tasks, or resisting the 
urge to smoke (for a meta-analysis of laboratory component studies see Levin et al. 2012), 
direct tests within therapy are lacking.  
Consequence Model for the Reduction of Suffering 
An opposing model based on most implicit and some explicit theories of 
psychopathology posits that increases in valued behaviors are possible only after symptoms/ 
struggling with symptoms have been removed or reduced (Consequence Model) (Ciarrochi, 
Robb, & Godsell, 2005). This suggests that the manifest symptoms are barriers to engaging in 
valued behaviors and removing those symptoms – and the suffering they promote – enables a 
patient to then freely choose these behaviors again. Likewise, this model logically suggests 
that struggle with symptoms would recede once the symptoms and the suffering they entail 
abate.  
Timing 
Research questions about the antecedents and consequences of change can be further 
specified with respect to timing within a course of treatment. That is, changes in valued 
behavior, struggle and suffering may occur more at the beginning, middle, or end of 
treatment. Knowing this again can help clinicians understand when to concentrate on which 
process in the course of behavior therapy. However, predictions about timing must be 
considered exploratory given the paucity of work on this in the area of PFT. Information 
derived from typical ACT intervention manual would suggest that although values are 
initially touched on in the early part of therapy, a heavier dose of acceptance occurs early in 
treatment with more emphasis on values later (Eifert & Forsyth, 2005; Eifert & Gloster, 2016; 
Hayes, Strosahl, & Wilson, 1999). Indirect evidence can be derived from the behavior 
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activation literature, which demonstrates that increases in activity lead to decreases in 
depression and addressing the relationship between values and activities occurs at the 
beginning of therapy (Dimidjian et al., 2006; Lejuez, Hopko, Acierno, Daughters, & Pagoto, 
2011).  
The purpose of the present study was to investigate the association and temporal order 
between valued behavior, struggling with symptoms, and suffering, during a standardized 
ACT intervention for patients with treatment-resistant cases with primary panic disorder. The 
research questions of this study thus examined which of the temporal models best fit the data. 
We evaluated three types of temporal models. First, we examined the antecedence models 
based on psychological flexibility theory, (equivalent to ACT theory; cf., Hayes et al., 2012), 
which posits that changes in valued action temporally precede changes in suffering 
(Antecedent Model 1) and that changes in struggle temporally precede changes in suffering 
(Antecedent Model 2). Second, we examined the consequence model, which in contrast 
posited that changes in suffering precede changes in the other variables (Consequence 
Model). Finally, we explored the timing of these processes in order to determine at what point 
in the standardized therapy the processes unfolded.  
Method 
Design 
 Details of the randomized controlled trail and its outcomes are described in detail 
elsewhere (Gloster et al., 2015). Patients (n = 43) diagnosed with panic disorder and/or 
agoraphobia (PD/ A) who were resistant to previous therapies (i.e., did not responded at all or 
not responded as expected to ≥ 25 sessions of empirically supported psychotherapy or 
approved pharmacological interventions at recommended dose and length) were randomized 
to immediate treatment (n = 33) or wait-list (n = 10). Eight participants from the waitlist were 
re-allocated to the ACT treatment following the waiting period. These patients did not differ 
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from patients in the immediate treatment condition on primary outcomes at the baseline. The 
current study thus included all patients who began treatment (n = 41), irrespective of whether 
they had immediate treatment (n = 33) or delayed treatment (n = 8). Independent raters 
diagnosed patients. The local internal review board approved the study.  
Participants 
Participants were largely female (68.3%), with an average age of 37.1 (SD = 9.1). In 
addition to PD/A, patients endorsed 2.0 comorbid disorders on average. The most common 
co-morbidities were social phobia (36.4%), specific phobia (36.4%), major depression 
(24.2%), pain disorder (21.2%), obsessive-compulsive disorder (18.2%), dysthymia (15.2%), 
and generalized anxiety disorder (15.2%).  Previous therapy experience was substantial: mean 
= 42.4/ median = 25.0 psychotherapy sessions and 2.1 valid psychopharmacological agents 
(for more details see Gloster et al., 2015). 
Additional inclusion criteria included age (18-65); primary diagnosis of panic disorder 
and/or agoraphobia; scored 1 SD above the mean of non-clinical sample (i.e., ≥ 1.5) on a scale 
of agoraphobic avoidance Mobility Inventory-Unaccompanied Subscale (MI; Chambless, 
Caputo, Jasin, Gracely, & Williams, 1985); ≥ “moderate” on clinician-rated functioning 
Clinical Global Impression (CGI; Guy, 1976); were not currently in another psychotherapy. 
Exclusion criteria included alcohol dependence; benzodiazepine or drug dependence; bipolar 
disorder; psychotic or eating disorders; or were actively suicidal. Participants were not 
permitted to initiate additional treatment during the study protocol.  
Intervention 
 A manual of Acceptance and Commitment Therapy (ACT) for anxiety disorders 
(Eifert & Forsyth, 2005) was adapted for this trial (Eifert & Gloster, 2016; Gloster et al., 
2015). This manual was already successfully employed in a randomized clinical trial 
comparing ACT with CBT (Arch et al., 2012). Treatment consisted of eight sessions (91-120 
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minutes) administered twice weekly over four weeks. The treatment targeted all core 
processes of the ACT model including changing the way one interacts with troubling 
thoughts/ feelings by reducing the unhelpful functions derived from treating the thoughts/ 
feelings literarily; increasing skills that allow one to non-judgmentally be aware of the  
present moment and awareness of a stable sense of self; and promoting patterns of action that 
are consistent with their values while reducing barriers that are perceived to impede such 
action. Valued behaviors were explicitly introduced in the first session with exercises and 
discussions about what the patients want their life to stand for and what they are currently 
doing in that regard. This theme became part of the treatment goal and was reviewed in each 
session.  
Therapists 
 Therapists were advanced-level graduate students in a psychotherapy training 
program. All therapists passed competency tests and received weekly supervision. Expert 
ratings of the therapy sessions indicated very good adherence and competence of the 
therapists (see Gloster et al., 2015 for details).  
Assessment 
 The process measures examined in this paper (i.e., valued behaviors, struggling, and 
suffering) were assessed at every session during treatment. With the goal of capturing session-
by-session change, we selected items designed for repeated measurement across therapy 
sessions that are sensitive to change. The items were taken from the manual used in this study 
(Eifert & Forsyth, 2005; Eifert & Gloster, 2016). Patients rated the items in an online format 
without the therapist present. Items assessed the past 24 hours in order to minimize recall bias 
and because therapy sessions occurred twice weekly. The exact wording was as follows. 
Suffering: “In the last 24 hours, how upset and distressed over anxiety were you?”; Struggle: 
“In the last 24 hours, how much effort did you put into making anxiety-related feelings or 
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thoughts go away (i.e., by suppressing them; distracting yourself; reassuring yourself or 
seeking reassurance from someone else)?”; and Valued Action: “How much have you engaged 
in behaviors that are in accord with your values and life goals?”. Each variable was assessed 
on a 0 – 10 scale with the anchors “none/not at all” to “extreme amount”. The average test-re-
test reliability of the items suffering, struggle and valued action across all sessions was: .50, 
.55, and .49 respectively.  
A full assessment battery was also administered, but not included in these analyses 
(for more details see Gloster et al., 2015).  
Statistical Analysis 
 Preliminary analysis. Means and standard deviations were calculated for the 
suffering, struggle and valued action across participants at each session. The standardized 
mean gain (ESsg) was estimated for examining the effect of session-by-session and 
cumulative change in suffering, struggle and valued behavior. The effect size measure ESsg is 
an appropriate measure for examining intra-individual change (Lipsey & Wilson, 2001). 
Univariate and parallel latent growth curve modeling (Duncan, Duncan, & Strycker, 2006) 
were used to assess the change in each process variable, irrespective of the timing of change. 
Latent growth curve analyses model the linear intraindividual change in the three variables 
across time while incorporating patients’ initial values. These models were used to test 
whether (i) change occurs in the three variables and (ii) whether the change in one variable is 
associated with the change in the other one, irrespective of timing. Preliminary analyses 
showed that parallel latent growth curve models with freely estimated slope factors and freely 
estimated associations between intercept and slope factors resulted in best model fit. The 
loading of the first session score was fixed to 0 and for the eighth session fixed to 1.0 for 
reasons of model identification for the two latent growth curves.  
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 Antecedent/consequence models. We examined the temporal dynamics between 
change in valued behavior, struggle, and suffering by latent difference score models (LDS; 
McArdle, 2001, 2009; Selig & Preacher, 2009). LDS models provide a general framework for 
the study of intraindividual change over time (McArdle, 2009).  The hypotheses, whether the 
effect of one process variable on subsequent change in the other process variable differs 
between the eight sessions, can be addressed by LDS. The LDS model includes 
autoregressive effects in which the intraindividual changes in a variable over time is a 
function of the level of that variable at the previous time point.  In a first step, univariate LDS 
models were evaluated for the three variables to assess the functional form of change. We 
evaluated a series of different univariate LDS models for the change of valued behavior, 
struggle, and suffering. These univariate analyses included the no change model, the constant 
change model, and the dual change model for the most appropriate modeling of change in 
each process variable). Finally, bivariate latent difference score models were estimated to 
determine the dynamics of change between two process variables. Bivariate LDS models 
provide an appealing feature for investigating whether change in a variable at each time-point 
is a function of prior level on the other variable, adjusting for autoregressive effects and non-
stationarity.  
A coupling parameter γ is included into the equations of two univariate LDS models 
representing the effect of one variable on the subsequent change in the other. The coupling 
parameter γ was included for both process variables examining a bidirectional dependency 
between the two process variables. LDS provide the possibility to study multivariate change 
processes and time-dependencies between two simultaneously processes with intraindividual 
changes over time that are not possible with other approaches such as random effect 
modeling. 
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 Timing. We investigated different patterns of coupling between the two univariate 
LDS models by restricting the path coefficients in the models. In more detail, the coupling 
parameter γ may be constant or may vary over treatment sessions. The decision about the 
most appropriate model was based on model fit indices. All path coefficients are reported as 
unstandardized coefficients. 
Model fit for competing parallel latent growth curve models, univariate and bivariate 
LDS models were evaluated by the Bayesian information criteria, root mean square error of 
approximation (RMSEA), standardized root mean square residual (SRMR), comparative fit 
index (CFI) and Tucker-Lewis index (TLI). 
We used the full-information maximum likelihood estimator due to missing data in 
some cases. This approach ensures the use of all available data for parameter estimation. 
Thus, also patients who started the treatment could be included in analyses, even if some 
sessions were incomplete. The specification of parallel latent growth curve models and 
univariate/ bivariate LDS models was evaluated in Mplus Version 6.1 (Muthén & Muthén, 
2011).  
Results 
Preliminary Analyses 
Each of the three process variables changed significantly during treatment. The mean 
and standard deviations for each session and the session-by-session and cumulative effect 
sizes for the three process variables are reported in Table 1 and Figure 1. Over the course of 
treatment, each of the three process variables suffering, struggle, and valued action changed 
with medium cumulative effects (suffering ESsg = .67; struggle ESsg = .76; valued action 
ESsg = .64). Suffering and struggle were highly correlated (Table 2) at each session, whereas 
suffering and valued action and struggle and valued action were not correlated more than 
moderately. Analyses derived from univariate latent growth curve modeling confirmed that 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
INCREASING VALUED BEHAVIORS PRECEDES REDUCTION IN SUFFERING 
 
12 
each of the process measures changed significantly across the eight sessions (mean growth 
slope estimates: suffering: -1.57 (SE = .56; 95% CI -2.66 , -.48); struggle: -2.39 (SE = .58; 
95% CI -3.52 , -1.25); and valued action: 1.17 (SE = .57; 95% CI .05 , 2.29). The session-by-
session effect sizes were determined for investigating whether the change in the three process 
variables occurred at different times during treatment.  
As a second preparatory step, we examined whether change in one process variable 
was associated with change in another irrespective of the timing of the change. This was 
examined using parallel latent growth curve modeling. Change in suffering and the change of 
struggle were significantly associated over all sessions (beta = 0.99 [0.12], p < 0.001) and 
change in valued action and the change of suffering were also significantly associated (beta = 
-0.64 [0.16], p = .014). This indicates that less change in suffering was associated with less 
change in struggle and to a lesser degree, a less change in valued action during treatment. We 
did not find a significant association across the entire treatment between changes in valued 
action and struggle. 
Antecedent & Consequence Models  
Having established the overall relationship between struggle and suffering, and values 
and suffering, we then examined whether change in one process variable was associated with 
subsequent change in the other process variables by using latent difference score models. Two 
sets of models were tested: one in which the coupling parameters were set to be equal across 
all 8 sessions and one in which they were allowed to be time varying. The final models with 
time-varying coupling coefficients provided most appropriate model fit suggesting that 
change in the variables was not uniform across the treatment (see supplementary section). A 
series of univariate latent difference score models were examined in preliminary analyses to 
determine the most appropriate model for change. Bivariate latent difference score models 
were specified after identifying the most appropriate univariate latent difference score model. 
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The parameters of primary interest in bivariate latent difference score models are the coupling 
parameters (γ). The coupling parameter γ represents the association of one variable on 
subsequent change in the other variable by adjusting for autoregressive effects (see Figure 2 
for an example of the model). The variance of suffering, struggle and valued action is 
partitioned into the true score and the measurement error in LDS as shown in Figure 2. Figure 
2 presents a path diagram as an example for the bivariate LDS model of suffering and valued 
action. The squares including the capital letters represent the observed scores, and the circles 
in the highest and lowest line their measurement errors. The latent true scores are presented 
by the circles including the lowercase letters (under/above the observed scores) for each 
session. The detailed indices for model-fit of the latent difference score models are reported in 
the supplementary table. In summary, the models with time-varying coupling coefficients 
provided an acceptable model fit indicated by a SRMR equal to or lower than .1.  
Table 3 displays the results of the LDS models. The relation between valued action 
and suffering (Antecedent Model 1) was clearly one-directional. The level of valued action 
significantly influenced the change in subsequent suffering, but the level of suffering did not 
significantly predict subsequent change in valued action (Consequence Model). That is, the 
more participants engaged in valued action, the less suffering was reported at the next session.  
The relationship between struggle and suffering appeared to be reciprocal in nature.   
Level of struggle was closely linked to the change in suffering at the following session 
(Antecedent Model 2). Although the relation was weaker, the level of suffering also predicted 
subsequent struggle (Consequence Model).  
In order to be thorough, we also examined the relationship between struggle and 
valued action. These two variables were did not significantly predict the change in each other 
throughout the course of the treatment.  
Timing 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
INCREASING VALUED BEHAVIORS PRECEDES REDUCTION IN SUFFERING 
 
14 
The magnitude of the effect of values on subsequent reduction in suffering seemed to 
be salient at the beginning of therapy then grew over the rest of the course of the therapy. 
Higher levels of valued action significantly predicted subsequent latent decrease in suffering 
for the second half of the treatment interval. Importantly, the relationship between values and 
subsequent suffering was two to four times greater than any other relationship observed.  
It is also striking that at the beginning of the treatment it was the level of struggle that 
influenced the change in subsequent suffering. At the middle of the treatment, the two 
variables appeared to be dynamically interrelated although the magnitude of the effect of 
struggle on subsequent suffering was always greater than the magnitude of the effect of 
suffering on subsequent struggle.  
Discussion 
This study examined the temporal process of change occurring during a standardized 
ACT treatment. To our knowledge, this study was the first to examine the temporal order of 
core processes of Psychological Flexibility Theory (i.e., valued behavior, struggle, and 
suffering) across the sessions of a standardized treatment and how each variable influenced 
each other during the treatment. The antecedent models showed that change in values and 
struggle occurred before change in suffering. The magnitude of the relationship between 
values and subsequent change in suffering was greater than any other observed relationship. 
In contrast, the consequence model, namely that suffering changes before values can change, 
was not supported by these analyses. With respect to our exploration of the timing of changes 
within the course of treatment, these data suggested that the importance of values was 
initiated at the beginning of therapy and renewed in the second half of therapy. The first half 
of therapy appeared to be more influenced by changes in struggle, which suggests the 
importance of acceptance work.    
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All three variables changed during treatment in a desired direction. Changes in valued 
action were independent of struggling, while there was a trend toward a negative association 
between valued action and suffering. Conversely, changes in suffering and struggling were bi-
directionally interdependent. This is important because valued actions affected subsequent 
change in suffering, but neither suffering nor struggling affected subsequent change in valued 
action.  
These analyses showed that increased valued action preceded decreases in suffering. 
The level of change in valued action significantly influenced the change in subsequent 
suffering, and the magnitude of this effect grew over the course of the therapy and was two to 
four times greater than any other relationship observed. The importance of this finding lies in 
the fact that it runs contrary to the expectation of many theories of psychotherapy, 
psychopathology, and arguably most patients who firmly believe reductions in suffering is a 
prerequisite to positive changes in valued behaviors. Indeed, this assumption is readily 
accepted in Western society in general (Hayes et al., 2012). Our data show that it is not 
necessary to first reduce suffering in order to increase engagement in what matters to an 
individual. Rather, engaging in what matters precedes reductions in suffering, at least as 
tested in this ACT trial. It is possible that when participants made judgments about suffering 
they also included some dimension of symptom severity in their judgment. The degree to 
which that is true would suggest that increases in valued behavior preceded change in this 
dimension as well.    
We observed a consistently strong relationship between struggling (attempts to control 
symptoms) and suffering across the treatment. Less change in struggle during treatment was 
associated with less change in suffering. Thus, the more people continued to struggle with 
their symptoms, the more they continued to suffer. Similarly, higher levels of struggle 
predicted greater subsequent increase in suffering. Although causality cannot be determined 
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in any of these observations, and alternate interpretations are possible such as people who 
suffer more may have a stronger desire to struggle, these results are consistent with the 
underlying theory (Hayes, Barnes-Holmes, & Roche, 2001). That is, as long as a patient 
follows inflexible internal rules stipulating that they “should” or “must” have control of their 
feelings and they mobilize efforts to achieve this, then the absence of control is associated 
with further suffering in the form of feelings such as insecurity, anxiety, or irritability. This 
suggests that a reduction in attempts to control anxiety (indicating growing psychological 
flexibility) should lead to reductions in suffering. It is important to note, however, that this 
line of reasoning does not imply that attempting to control symptoms is always a bad thing. 
Indeed it can be helpful as long as greater control is achievable. As indicated by many studies 
(Barlow, Gorman, Shear, & Woods, 2000; Craske & Barlow, 2007), increases in perceptions 
of control over symptoms are associated with positive outcomes. The crucial difference is 
between having control and trying to have control when this is not attainable. This 
differentiation between having control and striving for control when it is unattainable should 
be directly examined in future studies.   
These data were collected from the often-neglected population of treatment-resistant 
patients (Schlaepfer et al., 2012). The results suggest that concentrating on values is an 
important option to consider for these patients. Whereas we agree that reducing avoidance 
behaviors is ultimately an integral component of treatment for these patients (Taylor, 
Abramowitz, & McKay, 2012), starting with values work before such attempts may help 
facilitate change. For example, a treatment-resistant patient has by definition struggled with 
symptoms for some time and all their attempts to deal with the problem has been 
unsuccessful. Initiating the topic of values in this context while conveying the attitude that 
action in this area is both possible and important may expand their perspective beyond 
symptom reduction long enough to try out new things that in turn help build adaptive 
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repertoires. Towards this end, it is often necessary to collaboratively clarify patients’ values, 
particularly when dealing with patients with vague or seemingly conflicting values (Michalak, 
Heidenreich, & Hoyer, 2011).  
This study is limited in several ways. First, the sample size in a specific treatment-
resistant sample may limit generalizability. Second, although the assessment strategy was 
designed to examine these questions, the participants were not randomized across the 
hypotheses in this study and appropriate caution is needed given the post-hoc nature of these 
analyses. Third, the sequencing examined in this study was tested only on this manualized 
ACT therapy. Thus, the specificity vs. generalizability of these findings is not known. Future 
studies testing this sequencing in other therapies are required. Fourth, the items used in this 
study were developed within a previously tested manual with emphasis on clinical utility, 
appropriateness for repeated measurement (minimization in participant burden), face validity, 
and as demonstrated here are clearly sensitive to treatment changes. Nonetheless, further 
psychometric information is lacking and appropriate caution is needed. Future studies should 
consider including longer scales that are also practical for use in repeated session-by-session 
assessments.  Finally, this study did not include other competing mediator constructs that 
measure alternative processes such as inhibitory learning or maladaptive schema. Thus, the 
specificity beyond the measured variables is not known. Future studies should include 
additional competing mediator constructs.  
These limitations notwithstanding, these results have important practical clinical as 
well as theoretical implications. Clinically, our results suggest that therapists should pay 
attention to valued actions from the very beginning of treatment and do all they can to help 
people get moving in directions that bring them closer to their chosen values. The results also 
support the key ACT strategy to reduce patients’ struggle with symptoms by pointing out that 
they do not work in the long run and may actually serve to increase suffering. Theoretically, 
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models that address value-related behaviors and functioning should test the degree that 
changes in value-related behaviors is a necessary condition for positive outcomes and to 
which degree value-related behaviors function as a cause or consequence of other 
psychological changes. Optimistically, PFT appears promising for the treatment resistant 
population (Clarke, 2014; Gloster et al., 2015). Nevertheless, these results clearly need to be 
replicated in other samples and with other interventions that directly or indirectly promote 
these processes (Gloster et al., 2014). 
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Table 1 
 
Mean, standard deviation, and change scores across participants for 
suffering, struggle, &valued action at each session 
  
  
Estimates Weekly Change 
Cumulative 
Change 
 
Session Mean SD ESsg ESsg 
Suffering 1 5.41 2.81 - - 
2 4.82 2.98 .20 .20 
3 5.00 3.21 .06 .14 
4 4.97 2.74 .01 .16 
5 4.85 2.71 .05 .20 
6 3.58 2.29 .50 .71 
7 4.26 2.79 .27 .41 
  8 3.59 2.64 .25 .67 
Struggle 1 5.04 3.53 - - 
2 5.01 3.03 .01 .01 
3 4.47 2.70 .19 .18 
4 4.12 2.66 .13 .29 
5 3.62 2.68 .19 .45 
6 2.83 2.37 .31 .73 
7 3.46 2.44 .26 .52 
  8 2.81 2.21 .28 .76 
Valued 
Action 1 4.88 2.64 - - 
2 5.22 2.21 .14 .14 
3 5.86 2.33 .28 .39 
4 6.02 1.98 .08 .49 
5 5.83 2.67 .08 .36 
6 5.77 2.52 .02 .35 
7 6.54 2.02 .34 .71 
  8 6.55 2.59 .01 .64 
Note. ESsg = Standardized mean gain (effect size). 
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Table 2 
 
Correlations between process variables at each session 
 
 
Suffering and  
Struggle 
Suffering and  
Valued Action 
Struggle and  
Valued Action 
Session r p r p r p 
1 .90 <.001 -.10 .550 -.06 .726 
2 .86 <.001 .16 .345 .04 .812 
3 .77 <.001 -.44 .008 -.34 .045 
4 .82 <.001 -.38 .025 -.33 .049 
5 .73 <.001 -.32 .065 -.38 .024 
6 .88 <.001 -.14 .431 -.12 .492 
7 .66 <.001 -.24 .167 -.30 .077 
8 .81 <.001 -.23 .192 -.11 .532 
Note. Significant correlations are in boldface. 
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Table 3 
 
Results of Bivariate Latent Difference Score Models 
 
 
Suffering and Struggle Suffering and Valued Action Struggle and Valued Action 
 
Suffering 
(Consequence 
Model) 
Struggle 
 (Antecedent  
Model 2) 
Suffering 
(Consequence 
Model) 
Valued Action 
(Antecedent  
Model 1) 
Struggle Valued Action 
Initial Status 
      
 
Mean (SE); p 
value 5.47 (.44); <.001 5.03 (.57); <.001 5.32 (.42); <.001 4.81 (.37); <.001 5.02 (.54); <.001 5.25 (.43); <.001 
 
Variance (SE) 3.29 (1.69) 8.58 (2.74) 3.18 (1.43) 2.17 (.93) 7.05 (2.05) 3.77 (1.47) 
  
 
 
 
 
 Constant Change 
(α)  
 
 
 
 
 
 
Mean (SE); p 
value 3.92 (1.12); <.001 2.76 (.79); <.001 .55 (2.14); .797 -1.86 (1.33); .163 -.95 (.84); .255 7.78 (4.51); .085 
 
Variance (SE) 2.70 (1.54) 1.58 (.92) 3.29 (1.92) 1.77 (1.54) .10 (.16) 9.51 (12.08) 
       Bivariate 
Coupling (γ) 
Sufferingt-1  
-> ∆Strugglet 
Strugglet-1  
-> ∆Sufferingt 
Sufferingt-1  
-> ∆Valued Actiont 
Valued Actiont-1  
-> ∆Sufferingt 
Strugglet-1  
-> ∆Valued Actiont 
Valued Actiont-1  
-> ∆Strugglet 
 γ1 (SE); p value -.31 (.22); .156 1.02 (.34); .003 -.22 (.27); .421 -2.12 (1.07); .040 -1.08 (.76); .156 .21 (.11); .056 
 γ2 (SE); p value -.42 (.25); .095 .98 (.35); .005 .25 (.29); .399 -2.41 (1.47); .101 -1.12 (.76); .142 .12 (.13); .350 
 γ3 (SE); p value -.42 (.23); .071 1.07 (.37); .004 .27 (.33); .413 -2.51 (1.61); .120 -1.28 (.87); .139 .11 (.14); .433 
 γ4 (SE); p value -.45 (.22); .038 1.10 (.41); .008 .30 (.30); .322 -2.62 (1.59); .100 -1.41 (1.01); .161 .17 (.15); .259 
 γ5 (SE); p value -.58 (.22); .007 .85 (.45); .056 -.25 (.33); .450 -2.98 (1.51); .038 -1.58 (1.07); .141 .17 (.15); .242 
 γ6 (SE); p value -.44 (.24); .071 1.03 (.51); .044 .29 (.37); .434 -3.44 (1.75); .031 -1.93 (1.11); .082 .31 (.20); .131 
 γ7 (SE); p value -.61 (.23); .008 .81 (.46); .073 .23 (.40); .560 -3.74 (1.90); .041 -1.80 (1.28); .159 .14 (.17); .408 
       Model Fit1 
      
 
SRMR .08 .10 .09 
              
Note. SRMR = Standardized Root Mean Square Residual; 1 Detailed information on model-fit can be found in the supplementary table. 
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Figure 1. Absolute values of suffering, struggle, and valued action across sessions (spikes = 
95% confidence intervals of the mean for each session). 
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Figure 2. Example of a Bivariate Latent Difference Score Model to examine the effect of suffering (SU) on subsequent change in valued action 
(VA) and visa versa (*** p < .001; ** p < .01; * p < .05). Capitalized letters in squares represent the observed scores, lowercase letters in the circles 
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represent the latent variables, straight lines with single-headed arrows between two boxes represent the relation between two variables, line with 
double-headed arrows between two boxes represent an unexplained relation, line with double-headed arrows at one box represent residual variance. 
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Highlights 
 
• Increased (re-)engagement in valued behaviors precedes reductions in suffering. 
 
 
• Working on valued behaviors should commence at the beginning of treatment. 
 
 
• Suffering, struggle, and values all change in therapeutically desired directions. 
 
 
